AtriCure Sells 5,000 Shares: Insider Move or Pattern Worth Watching?
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
Understanding the key principles of financial planning is essential. Discover how these principles can shape your financial decisions.
26,905 articlesA senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
As signs point to a softer economy in 2026, dividend-focused ETFs can provide ballast. This guide identifies three re...
As military spending climbs worldwide, select defense stocks poised benefit due to diversified portfolios, strong cas...
When bitcoin dips under $70k amid a sharp stock sell-off tied to a hawkish FED hold, traders scramble for direction. ...
Oklo faces a pivotal moment after July. This piece explains a single catalyst investors should watch, the potential s...
A private defense contractor is pushing the Navy toward autonomous, unmanned surface ships. This article explains the...
Regulatory headlines have a way of rattling investors, especially in high-growth tech sectors. This article dives int...
CytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Looking to ride a big move in a small-cap space? Learn how to spot a small-cap growth stock before it hits its next e...
If SpaceX eyes an IPO, the idea of a space-faring civilization could reshape how investors evaluate growth and risk. ...
Dive into gigacloud (gct) 2025 earnings with a clear, actionable analysis. We break down the Q4 results, growth drive...